Why Passwords Are Still a Developer's Problem in 2026. The case against password-based authentication is well-established in the IAM community, but the practical implications for ...

1 Department of Computer and Instructional Technologies Education, Gazi Faculty of Education, Gazi University, Ankara, Türkiye. 2 Department of Forensic Informatics, Institute of Informatics, Gazi ...

Using an AI coding assistant to migrate an application from one programming language to another wasn’t as easy as it looked. Here are three takeaways.

Google may finally be ready to fix one of the Pixel’s most frustrating flaws. According to an exclusive report from Android Authority, Google is developing a new advanced facial recognition system ...

A fake $TEMU crypto airdrop uses the ClickFix trick to make victims run malware themselves and quietly installs a remote-access backdoor.

READING, Pa. - The Federal Railroad Administration (FRA) made it official on Friday. The plan to restore passenger train service between Reading and Philadelphia has taken a big step after being ...

Biometrics are a core part of any smartphone nowadays, and Google Pixel is one of the few brands that balances both fingerprint and face unlock properly. But it seems Google wants to take things a ...

AI startup Anthropic's claim of automating COBOL modernization sent IBM's stock plummeting, wiping billions off its market value. The decades-old language, still powering critical systems, faces a ...

Tycoon2FA has become a leading phishing-as-a-service (PhaaS) platforms, enabling campaigns that reach over 500,000 organizations monthly, prompting Microsoft’s Digital Crimes Unit (DCU) to work with ...

This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...